Related Experiment Video
Updated: Dec 10, 2025

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
Overactive bladder syndrome: Management and treatment options
Alexander Hutchinson1, Alexander Nesbitt2, Andre Joshi3
1MBBS, MSc, BA, Resident Medical Officer, Department of Urology, Mater Hospital, Qld.
Overactive bladder (OAB) is a common condition causing urinary urgency and frequency. Treatment follows a stepwise approach, starting with conservative measures and progressing to medications or minimally invasive procedures to improve quality of life.
Area of Science:
- Urology
- Nephrology
Background:
- Overactive bladder (OAB) is a prevalent condition affecting over 10% of the population.
- Characterized by urinary urgency, frequency, and nocturia without detectable disease.
Purpose of the Study:
- To summarize the stepwise management of OAB.
- Focus on improving patient quality of life and reducing healthcare costs.
Main Methods:
- OAB diagnosis involves a targeted history and urogenital examination.
- Treatment progresses from conservative measures to pharmacological and procedural interventions.
Main Results:
- First-line conservative treatments include lifestyle modifications and pelvic floor exercises.
- Anticholinergic medications like oxybutynin are a pharmacological option.
- Refractory cases may benefit from urology specialist consultation and minimally invasive procedures.
Conclusions:
- A stepwise approach to OAB management is effective.
- Treatment aims to enhance patient well-being and optimize healthcare resource utilization.
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

